Emily M. Ko, MD, MSCR
Gynecologic Oncology
Headshot of Emily M. Ko, MD, MSCR

Emily M. Ko, MD, MSCR

Gynecologic Oncology
Accepting new patients
Sees patients age 12 and up
Penn Gynecologic Oncology Washington Square
View 1 additional location
Headshot of Emily M. Ko, MD, MSCR
Penn Medicine Provider

About me

  • Medical Director, Pennsylvania Hospital Abramson Cancer Center
  • Director, Gynecologic Oncology Populations Sciences Research Program
  • Director, REACH--Research Equity Center for Gynecologic Cancers and Health
  • Gynecologic Oncology Fellowship: Associate Program Director
  • Senior Fellow, Leonard Davis Institute for Health Economics
  • John J. Mikuta, MD Professor in Gynecological Oncology

My education and training

  • University of MassachusettsMedical School
  • Brigham and Women's Hospital - Massachusetts General HospitalResidency
  • University of North Carolina at Chapel HillFellowship

Spoken languages

English
English
Español
Spanish
中文 / 普通话
Chinese - Mandarin

Reviews

Average Rating

373 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
August 2026
knowledgeable and does a good job making sure i fully understand options and approaches
Anonymous
August 2026
i hope no one ever has to see an oncologist, but if you do dr. ko is the best!
Anonymous
August 2026
it was just lovely. i found out the answers. i needed
Anonymous
August 2026
patient and informative

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Ko is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Ko E, Funk MJ, Clark L, Brewster W Did GOG99 and Portec1 Change Clinical Practice in the United States? , Gynecol Oncol, 129(1):12-17: 2013


Ko EM, Muto MG, Berkowitz RS, Feltmate CM Robotic versus open radical hysterectomy: a comparative study at a single institution. , Gynecol Oncol, 111(3):425-30: 2008


Semere LG, Ko E, Johnson NR, Vitonis AF, Phang LJ, Cramer DW, Mutter GL Endometrial intraepithelial neoplasia clinical correlates and outcomes. , Obstet Gynecol, 118(1):21-8: 2011


Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LaJ, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump V Metformin is associated with improved survival in endometrial cancer. , Gynecol Oncol, 132(2):438-42: 2013


Ko EM, Stürmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ Metformin and the risk of endometrial cancer: A population-based cohort study. , Gynecol Oncol, 136(2):341-7: 2015


Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump VL The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. , Gynecol Oncol, 133(1):28-32: 2014


Haggerty A, Huepenbecker S, Sarwer D, Spitzer J, Raggio G, Chu C, Ko EM, Allison K The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer. , Gynecol Oncol, 140(2):239-44: 2016


Clark LH, Jackson AL, Gehrig PA, Bae-Jump V, Van Le L, Ko EM Adjuvant treatment and clinical trials in elderly with endometrial cancer: a time for change? , Int J Gynecol Cancer, 26(2):282-9: 2016


Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Ko E Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. , Int J Gynecol Cancer, 27(3):581-587: 2017


Cory L, Latif N, Brensinger C, Zhang X, Giuntoli RL 2nd, Burger RA, Morgan M, Ko E Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications. , Obstet Gynecol, 130(2):285-295: 2017